Capricor Therapeutics, Inc.
CAPR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $0 | -$25,911 | -$24,392 | -$7,117 |
| Dep. & Amort. | $246,735 | $486 | $405 | $376 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7,368,920 | $3,647 | $5,739 | $2,296 |
| Change in WC | $0 | $1,672 | $11,679 | -$10,448 |
| Other Non-Cash | -$7,615,655 | -$17 | $134 | $96 |
| Operating Cash Flow | $0 | -$20,122 | -$6,434 | -$14,796 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1,450 | -$1,140 | -$735 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$59,996 | -$18,182 | -$139,364 |
| Inv. Sales/Matur. | $0 | $75,995 | $43,213 | $16,717 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $14,549 | $23,891 | -$123,382 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $20 | $50 | $80,840 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $248 |
| Financing Cash Flow | $0 | $20 | $50 | $81,088 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $0 | -$5,553 | $17,508 | -$57,090 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $28,795 | $11,287 | $68,377 |
| End Cash | $0 | $23,241 | $28,795 | $11,287 |
| Free Cash Flow | $0 | -$21,572 | -$7,574 | -$15,531 |